Lymphoma & Leukaemia Research Review, Issue 32

In this issue:

Decitabine + camrelizumab in R/R Hodgkin lymphoma
Rituximab ± idelalisib then open-label idelalisib in CLL
Paternal occupational exposures and childhood lymphoma
Anti-PD1 therapy in Hodgkin lymphoma ± alloSCT
Anthracycline dose optimisation in DLBCL
Early disease progression and poor survival in follicular lymphoma
Fratricide-resistant CD1aspecific CAR T cells
Lenalidomide + rituximab in marginal zone lymphoma
Optimized induction of mitochondrial apoptosis in BCR-ABL+ ALL
Poor prognosis of chromosome 7 clonal aberrations in Ph-negative CML

Download PDF Subscribe